<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13</article-id><article-id pub-id-type="publisher-id">2006MOLVIS</article-id><article-id pub-id-type="pmid">17277738</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>FOXL2</italic> mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jinling</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Qingjiong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China</aff><aff id="aff2"><label>2</label>Eye Hospital, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China</aff></contrib-group><author-notes><fn><p>(The first two authors contributed equally to this publication)</p></fn><corresp id="cor1">Correspondence to: Qingjiong Zhang, MD, PhD, Ophthalmic Genetics &#x00026; Molecular Biology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, 54 Xianlie Road, Guangzhou 510060, China; Phone: (+86)-20-87330422; FAX: (+86)-20-87333271; email: <email xlink:href="qingjiongzhang@yahoo.com">qingjiongzhang@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>26</day><month>1</month><year>2007</year></pub-date><volume>13</volume><fpage>108</fpage><lpage>113</lpage><history><date date-type="received"><day>08</day><month>12</month><year>2006</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2007</year></date></history><permissions><copyright-year>2007</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant disorder where eyelid malformation associated with (type I) or without (type II) premature ovarian failure (POF). It is ascribed to mutations in the forkhead transcriptional factor2 (<italic>FOXL2</italic>) gene. The purpose of this study is to identify mutations in <italic>FOXL2</italic> of Chinese patients with BPES.</p></sec><sec sec-type="methods"><title>Methods</title><p>Genomic DNA was prepared from leucocytes of peripheral venous blood. The coding regions and nearby intron sequences of <italic>FOXL2</italic> were analyzed by cycle and cloning sequencing.</p></sec><sec><title>Results</title><p>Four mutations in <italic>FOXL2</italic> were identified in six families, including c.241T&#x0003e;C, c.650C&#x0003e;G, c.804dupC, and c.672_701dup. Of the four, the c.241T&#x0003e;C and c.650C&#x0003e;G were novel and would result in missense changes of the encoded proteins, i.e., p.Tyr81His and p.Ser217Cys, respectively. The c.672_701dup (p.Ala224_Ala234dup) was detected in three families, indicating a mutation hotspot. The c.804dupC (p.Gly269ArgfsX265) mutation was found in one family.</p></sec><sec><title>Conclusions</title><p>Our results expand the spectrum of <italic>FOXL2</italic> mutations and confirm the mutation hotspot in <italic>FOXL2</italic>.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES, OMIM <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?omim=110100">110100</ext-link>) is a rare autosomal dominant disease with a prevalence of about 1 in 50,000 [<xref ref-type="bibr" rid="r1">1</xref>]. Clinically, BPES has been divided into two subsets depending on the association of ocular malformation with (type I) or without (type II) premature ovarian failure (POF) [<xref ref-type="bibr" rid="r2">2</xref>]. Genetically, however, both types are caused by mutations in <italic>FOXL2</italic>, and a genotype-phenotype correlation has been described in some cases [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r4">4</xref>].</p><p>The human <italic>FOXL2</italic> gene (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?omim=605597">605597</ext-link>), located at 3q23, is a member of winged/forkhead transcription factor gene family [<xref ref-type="bibr" rid="r5">5</xref>]. This single-exon gene codes a protein with 376 residues, which consists of a DNA-binding forkhead domain (resudes 52-152) and a polyalanine domain (residues 221-234) [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. A number of mutations in <italic>FOXL2</italic> have been identified [<xref ref-type="bibr" rid="r8">8</xref>], including six novel mutations in the Chinese population [<xref ref-type="bibr" rid="r9">9</xref>-<xref ref-type="bibr" rid="r11">11</xref>].</p><p>Here, we report four mutations identified in six Chinese families with BPES. Two novel missense mutations were associated with BPES type II.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>Thirteen probands with BPES from unrelated families were collected from the Zhongshan Ophthalmic Center. Informed consent conforming to the tenets of the Declaration of Helsinki and following the Guidance of Sample Collection of Human Genetic Diseases (863-Plan) by the Ministry of Public Health of China was obtained from all participated individuals or their guardians prior to the study. The diagnosis of BPES was based on criteria previously established [<xref ref-type="bibr" rid="r12">12</xref>] with exclusion of microphthalmia.</p></sec><sec><title>Mutation Analysis</title><p>Genomic DNA was prepared from leucocytes of peripheral venous blood [<xref ref-type="bibr" rid="r13">13</xref>]. Amplification of the genomic fragments encompassing <italic>FOXL2</italic> coding regions (NCBI human genome build 35.1, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NC_000003">NC_000003</ext-link> for gDNA, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_023067">NM_023067</ext-link> for mRNA, and <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=NP_075555">NP_075555</ext-link> for protein) was carried out by PCR using primers as follows: AF: 5'-CAG CGC CTG GAG CGG AGA G-3', AR: 5'-CTT GCC GGG CTG GAA GTG C-3', BF: 5'-GAC CCG GCC TGC GAA GAC A-3', BR: 5'-GGC CGC GTG CAG ATG GTG T-3', CF: 5'-CGC GGC CGC TGT GGT CAA G-3', CR: 5'-GCT GGC GGC GGC GTC GTC-3'. The sizes of the amplified DNA fragments are 545 bp, 517 bp, and 500 bp, respectively.</p><p>PCR amplification was carried out initially at 95 &#x000b0;C for 8 min, followed by 5 cycles at 94 &#x000b0;C for 40 s, at 68 &#x000b0;C for 40 s, at 72 &#x000b0;C for 40 s, then 5 cycles at 94 &#x000b0;C for 40 s, at 66 &#x000b0;C for 40 s, at 72 &#x000b0;C for 40 s, and a further 30 cycles at 94 &#x000b0;C for 40 s, at 64 &#x000b0;C for 40 s, at 72 &#x000b0;C for 40 s, and finally an elongation step at 72 &#x000b0;C for 5 min. Due to the high GC-rich nature of <italic>FOXL2</italic>, an additional 10% dimethylsulfoxide and 10% glycerol were added to the PCR mixture in order to successfully amplify the genomic fragments.</p><p>Direct sequencing of the PCR products was performed with an ABI BigDye Terminator Cycle Sequencing Kit v3.1 (ABI Applied Biosystem, Foster City, CA), using an ABI 3100 Genetic Analyzer. Sequencing results from patients as well as the <italic>FOXL2</italic> consensus sequences from the NCBI Human Genome Database (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NC_000003">NC_000003</ext-link>) were imported into the SeqManII program of the Lasergene package (DNAStar Inc., Madison, WI) and then aligned to identify variations. Each mutation was confirmed by bidirectional sequencing. Mutation description followed the nomenclature recommended by the Human Genomic Variation Society (<ext-link ext-link-type="uri" xlink:href="http://www.hgvs.org/mutnomen/">HGVS</ext-link>).</p><p>Any variation detected in <italic>FOXL2</italic> was further evaluated in available family members as well as in 100 normal controls by heteroduplex-SSCP analysis as described previously [<xref ref-type="bibr" rid="r14">14</xref>]. Two additional pairs of primers were used for heteroduplex-SSCP analysis. The sequence of these primers were: DF: 5'- CCG TAA GCG GAC TCG TGC-3', DR: 5'- AGT AGT TGC CCT TGC GCT C-3', EF: 5'- CGC ACT TCC AGC CCG GCA A-3', and ER: 5'- TGT GTA CGG CCC GTA CGA-3'.</p><p>In addition, one variation of insertions with multiple nucleotides that was found in three families was further analyzed by cloning sequencing. PCR products harboring this mutation were subcloned to pMD18-T Simple Vector (TaKaRa BIO, Japan) according to the manufacture's instructions. Clones with the mutant allele as well as the normal allele were selected by using heteroduplex-SSCP analysis. Sequence of the cloned fragment was identified by cycle sequencing as described above. Mutations were confirmed by sequencing three positive clones from each family. One mutation, c.241T&#x0003e;C, was further analyzed by PCR-RFLP analysis since the mutation creates a new <italic>FOK</italic>I site.</p></sec></sec><sec sec-type="results"><title>Results</title><p>All patients demonstrated typical features of BPES, including small palpebral fissures, ptosis of the eyelids, and epicanthus inversus (<xref ref-type="fig" rid="f1">Figure 1</xref>). Upon complete sequencing analysis of <italic>FOXL2</italic> for 13 probands with BPES, four heterozygous mutations were found in six probands, including c.241T&#x0003e;C, c.650C&#x0003e;G, c.804dupC, and c.672_701dup (<xref ref-type="fig" rid="f2">Figure 2</xref>; <xref ref-type="table" rid="t1">Table 1</xref>). Of the four, c.241T&#x0003e;C and c.650C&#x0003e;G are novel. All four heterozygous mutations were further detected by heteroduplex-SSCP analysis, and one (c.241T&#x0003e;C) was further detected by <italic>FOK</italic>I digestion (<xref ref-type="fig" rid="f3">Figure 3</xref>). These mutations were also present in affected patients from corresponding families but neither in unaffected individuals nor in 100 controls.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Clinical phenotype of a Chinese patient with BPES. A photo of the eyelid area from a 40 years old man (III:1 from family E in <xref ref-type="fig" rid="f3">Figure 3</xref>) demonstrated typical phenotype of BPES. The horizontal diameter of his cornea was 11.5 mm for both eyes. Ultrasound A-scan recorded an axial length of 24.19 mm/OD and 24.43 mm/OS. His refractive measurement was -3.00DCX180&#x000b0;/OD and -4.50DCX180&#x000b0;/OS.</p></caption><graphic xlink:href="mv-v13-108-f1"/></fig><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Sequencing results of the two novel mutations in <italic>FOXL2.</italic> Sequence chromatograms of Family A (<bold>A</bold>) and family B (<bold>B</bold>), and their corresponding normal sequences. The underline below each sequence highlights the codon containing the mutation.</p></caption><graphic xlink:href="mv-v13-108-f2"/></fig><table-wrap id="t1" position="float"><label>Table 1</label><caption><title><italic>FOXL2</italic> mutations detected in Chinese patients with BPES.</title></caption><table frame="hsides" rules="groups"><col width="52" span="1"/><col width="79" span="1"/><col width="69" span="1"/><col width="73" span="1"/><col width="105" span="1"/><col width="61" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Family</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>DNA change</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Mutation type</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Location</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Protein change</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>BPES</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">c.241T&#x0003e;C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Missense<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Forkhead<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Tyr81His<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Type II<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">B<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">c.650C&#x0003e;G<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Missense<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Immediately upstream polyalanine<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ser21Cys<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Type II<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">c.804dupC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Insertion<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Downstream of polyalanine<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gly269ArgfsX265<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Unknown<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">D<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">c.672_701dup<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Duplication<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Polyalanine domain<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ala224_Ala234dup<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Unknown<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">E<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">c.672_701dup<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Duplication<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Polyalanine domain<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ala224_Ala234dup<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Type II<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">F</td><td valign="top" align="left" rowspan="1" colspan="1">c.672_701dup</td><td valign="top" align="left" rowspan="1" colspan="1">Duplication</td><td valign="top" align="left" rowspan="1" colspan="1">Polyalanine domain</td><td valign="top" align="left" rowspan="1" colspan="1">Ala224_Ala234dup</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td></tr></tbody></table><table-wrap-foot><p>Subtypes of BPES in families C, D, and F are unknown, as there were no female patients (families C and F) or the female patients were too young (family D, where the two female patients were only 4 or 2 years old, respectively).</p></table-wrap-foot></table-wrap><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Pedigrees and heteroduplex-SSCP analysis. Pedigrees of the different families (A, B, C, D, E, and F) are shown. Black filled symbols indicated patients affected with BPES in each family. The "+/+" or "+/-" sign indicated individuals analyzed with normal sequences or heterozygous mutation in <italic>FOXL2</italic>, respectively. The "M" under each lane indicated mutation, the "N" represented normal individuals, and "N+M" represented a mixture of PCR products resulted from normal and mutant clones. In addition, results of FOKI digestion for family A were present at the bottom of <xref ref-type="fig" rid="f1">Figure 1A</xref>. The c.241T&#x0003e;C mutation in family A creates an additional <italic>FOK</italic>I site. By <italic>FOK</italic>I digestion of the 545 bp PCR product, normal allele yielded two fragments (340 bp and 205 bp), but the mutant allele yielded three fragments (275 bp, 205 bp, and 65 bp). Patients with the heterozygous c.241T&#x0003e;C mutation had four bands (only three bands were shown in the figure) as compared to normal individuals with two bands.</p></caption><graphic xlink:href="mv-v13-108-f3"/></fig><p>The c.241T&#x0003e;C (p.Tyr81His) mutation results in substitution of a charge-free tyrosine with a charge-positive basic hydrophilic histidine within the forkhead domain. The c.650C&#x0003e;G (p.Ser217Cys) mutation is located immediately upstream of the polyalanine domain. The tyrosine at position 81 and the serine at position 217 are well conserved in <italic>FOXL2</italic> by ClustalW analysis of 11 orthologs from related vertebrate species (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Multiple alignment of 11 FOXL2 orthologs. This demonstrated high conservation of residues involved by the p.Tyr81His and p.Ser217Cys mutation. The resource for the 11 FOXL2 orthologs was as follows: human (<italic>Homo sapiens</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=NP_075555">NP_075555</ext-link>), mouse (<italic>Mus musculus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=NP_036150">NP_036150</ext-link>), pig (<italic>Sus scrofa</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=AAQ91845">AAQ91845</ext-link>), rabbit (<italic>Oryctolagus cuniculus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=AAQ91846">AAQ91846</ext-link>), rat (<italic>Rattus norvegicus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=XP_345976">XP_345976</ext-link>), mole vole (<italic>Ellobius lutescens</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=AAV30684">AAV30684</ext-link>), cow (<italic>Bos taurus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=NP_001026920">NP_001026920</ext-link>), goat (<italic>Capra hircus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=AAM52099">AAM52099</ext-link>), chicken (<italic>Gallus gallus</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=NP_001012630">NP_001012630</ext-link>), zebrafish (<italic>Danio rerio</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=XP_698915">XP_698915</ext-link>), and salmon trout (<italic>Oncorhynchus mykiss</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbprot=AAS87040">AAS87040</ext-link>).</p></caption><graphic xlink:href="mv-v13-108-f4"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p><italic>FOXL2</italic> encodes a forkhead transcription factor containing a forkhead domain for DNA-binding and a polyalanine domain of uncertain function. Strong expression of <italic>FOXL2</italic> has been found in eyelids [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r15">15</xref>], developing periocular muscles, and surrounding tissues [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Of the four mutations identified in this study, the c.241T&#x0003e;C affected the forkhead domain, while the other three (c.650C&#x0003e;G, c.804dupC, and c.672_701dup) were located upstream, within, and downstream of the polyalanine domain, respectively.</p><p>Missense mutations in <italic>FOXL2</italic> reported so far usually occurred at the forkhead domain [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r17">17</xref>-<xref ref-type="bibr" rid="r19">19</xref>], except two, such as c.650C&#x0003e;T in a Belgian family [<xref ref-type="bibr" rid="r4">4</xref>] and c.644A&#x0003e;G in a five-generation family from south-India [<xref ref-type="bibr" rid="r20">20</xref>]. The clinical subtypes of the patients with the c.650C&#x0003e;T and c.644A&#x0003e;G mutations were unknown. The novel c.650C&#x0003e;G (p. Ser217Cys) mutation identified in Chinese family B occurred at the same site as that found in the Belgian family, which is located immediately upstream of the polyalanine domain. The serine at position 217 is well conserved in 11 orthologs (<xref ref-type="fig" rid="f4">Figure 4</xref>). It has been shown that mutations affecting the polyalanine domain induce extensive nuclear and cytoplasmic protein aggregation [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. Missense changes have been suggested to act as null allele leading to BPES phenotype due to haploinsufficiency [<xref ref-type="bibr" rid="r4">4</xref>] or dominant-negative effect [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r23">23</xref>].</p><p>It has been suggested that <italic>FOXL2</italic> mutations truncating the protein led to BPES type I while those extending the mutant protein were associated with type II [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r4">4</xref>]. However, intra- and inter-family phenotypic variations have been found [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>] so that this genotype-phenotype correlation might not be general [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r26">26</xref>]. The c.804dupC mutation has been shown to cause both types of BPES [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r25">25</xref>], and the c.672_701dup causing polyalanine expansion most likely leads to BPES type II [<xref ref-type="bibr" rid="r19">19</xref>]. Missense mutations have been associated with both BPES type I [<xref ref-type="bibr" rid="r17">17</xref>] and II [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. The patients from families A and B in this study, with novel c.241T&#x0003e;C and c.650C&#x0003e;G mutations, respectively, had type II BPES. The c.650C&#x0003e;G mutation is the first mutation described that occurs immediately upstream of the polyalanine domain and associated with type II BPES. This may raise a possibility that the region containing the c.650C&#x0003e;G mutation is of importance for <italic>FOXL2</italic> function.</p><p>The c.672_701dup (p.Ala224_Ala234dup) was found in families D, E, and F (<xref ref-type="table" rid="t1">Table 1</xref>), consistent with a mutation hotspot. To check the origin of the c.672_701dup mutation in three families (families D, E, and F in <xref ref-type="fig" rid="f3">Figure 3</xref>), six SNPs (including <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs13325788">rs13325788</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs2291252">rs2291252</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs28937885">rs28937885</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs7432551">rs7432551</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs28937884">rs28937884</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs11924939">rs11924939</ext-link>) were analyzed (<xref ref-type="table" rid="t2">Table 2</xref>). The SNP at <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs2291252">rs2291252</ext-link> is different between patient II:1 from family D and patient III:1 from family E, which may suggest a different origin of the mutant allele. The mutation in family F is most likely a de novo event as BPES was not present in the patients' parents although the SNPs in the patient II:1 in family F were the same as that of II:1 in family D. It has been reported that 30% of the <italic>FOXL2</italic> mutations lead to polyalanine expansion [<xref ref-type="bibr" rid="r19">19</xref>]. The c.672_701dup has been found in BPES families of Caucasian [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r27">27</xref>,<xref ref-type="bibr" rid="r28">28</xref>] and Asian origin [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r29">29</xref>].</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Results of SNPs analysis of the three families with the c.672_701dup mutation.</title></caption><table frame="hsides" rules="groups"><col width="56" span="1"/><col width="47" span="1"/><col width="33" span="1"/><col width="81" span="1"/><col width="74" span="1"/><col width="63" span="1"/><col width="72" span="1"/><col width="71" span="1"/><col width="72" span="1"/><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><bold>Family</bold><hr/></td><td rowspan="2" colspan="2" valign="top" align="center"><bold>Patient</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Upstream of FOXL2</bold><hr/></td><td colspan="3" valign="top" align="center" rowspan="1"><bold>Inside FOXL2</bold><hr/></td><td colspan="2" valign="top" align="center" rowspan="1"><bold>Downstream of FOXL2</bold><hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1"><bold>rs11924939</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>rs28937885</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>rs7432551</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>rs28937884</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>rs13325788</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>rs2291252</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">d<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">II:1<hr/></td><td colspan="2" valign="top" align="center" rowspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">e<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">III:1<hr/></td><td colspan="2" valign="top" align="center" rowspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">f</td><td valign="top" align="center" rowspan="1" colspan="1">II:1</td><td colspan="2" valign="top" align="center" rowspan="1">C</td><td valign="top" align="center" rowspan="1" colspan="1">T</td><td valign="top" align="center" rowspan="1" colspan="1">C</td><td valign="top" align="center" rowspan="1" colspan="1">T</td><td valign="top" align="center" rowspan="1" colspan="1">G</td><td valign="top" align="center" rowspan="1" colspan="1">C</td></tr></tbody></table><table-wrap-foot><p>The origin of the c.672_701dup mutation in family D is different from family E as they have different SNP at <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?snp=rs2291252">rs2291252</ext-link>. This mutation in family F is a de novo event, although patient II:1 in family F shares the same haplogroup of the six SNPs with that of family D.</p></table-wrap-foot></table-wrap><p>In summary, we identified two novel and two known mutations in <italic>FOXL2</italic> of six Chinese families with BPES. The two novel mutations are the first reported instances that were associated with BPES type II. Our results expanded the spectrum of <italic>FOXL2</italic> mutations and confirmed the mutation hotspot in <italic>FOXL2</italic>.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors thank all patients and family members for their participation. This study was supported in part by the National 863 Plan of China (Z19-01-04-02 to QZ), National Natural Science Foundation of China (30572006 to QZ), and Foundation from the Ministry of Education of China (20050558073 to QZ).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oley</surname><given-names>C</given-names></name><name><surname>Baraitser</surname><given-names>M</given-names></name></person-group><article-title>Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES syndrome).</article-title><source>J Med Genet</source><year>1988</year><volume>25</volume><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">3270326</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zlotogora</surname><given-names>J</given-names></name><name><surname>Sagi</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>T</given-names></name></person-group><article-title>The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types.</article-title><source>Am J Hum Genet</source><year>1983</year><volume>35</volume><fpage>1020</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">6613996</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crisponi</surname><given-names>L</given-names></name><name><surname>Deiana</surname><given-names>M</given-names></name><name><surname>Loi</surname><given-names>A</given-names></name><name><surname>Chiappe</surname><given-names>F</given-names></name><name><surname>Uda</surname><given-names>M</given-names></name><name><surname>Amati</surname><given-names>P</given-names></name><name><surname>Bisceglia</surname><given-names>L</given-names></name><name><surname>Zelante</surname><given-names>L</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Porcu</surname><given-names>S</given-names></name><name><surname>Ristaldi</surname><given-names>MS</given-names></name><name><surname>Marzella</surname><given-names>R</given-names></name><name><surname>Rocchi</surname><given-names>M</given-names></name><name><surname>Nicolino</surname><given-names>M</given-names></name><name><surname>Lienhardt-Roussie</surname><given-names>A</given-names></name><name><surname>Nivelon</surname><given-names>A</given-names></name><name><surname>Verloes</surname><given-names>A</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Bonneau</surname><given-names>D</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Pilia</surname><given-names>G</given-names></name></person-group><article-title>The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.</article-title><source>Nat Genet</source><year>2001</year><volume>27</volume><fpage>159</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">11175783</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Baere</surname><given-names>E</given-names></name><name><surname>Dixon</surname><given-names>MJ</given-names></name><name><surname>Small</surname><given-names>KW</given-names></name><name><surname>Jabs</surname><given-names>EW</given-names></name><name><surname>Leroy</surname><given-names>BP</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Gillerot</surname><given-names>Y</given-names></name><name><surname>Mortier</surname><given-names>G</given-names></name><name><surname>Meire</surname><given-names>F</given-names></name><name><surname>Van Maldergem</surname><given-names>L</given-names></name><name><surname>Courtens</surname><given-names>W</given-names></name><name><surname>Hjalgrim</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Liebaers</surname><given-names>I</given-names></name><name><surname>Van Regemorter</surname><given-names>N</given-names></name><name><surname>Touraine</surname><given-names>P</given-names></name><name><surname>Praphanphoj</surname><given-names>V</given-names></name><name><surname>Verloes</surname><given-names>A</given-names></name><name><surname>Udar</surname><given-names>N</given-names></name><name><surname>Yellore</surname><given-names>V</given-names></name><name><surname>Chalukya</surname><given-names>M</given-names></name><name><surname>Yelchits</surname><given-names>S</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Kuttenn</surname><given-names>F</given-names></name><name><surname>Fellous</surname><given-names>M</given-names></name><name><surname>Veitia</surname><given-names>R</given-names></name><name><surname>Messiaen</surname><given-names>L</given-names></name></person-group><article-title>Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.</article-title><source>Hum Mol Genet</source><year>2001</year><volume>10</volume><fpage>1591</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">11468277</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>P</given-names></name><name><surname>Mahlapuu</surname><given-names>M</given-names></name></person-group><article-title>Forkhead transcription factors: key players in development and metabolism.</article-title><source>Dev Biol</source><year>2002</year><volume>250</volume><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12297093</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>SA</given-names></name><name><surname>Akers</surname><given-names>L</given-names></name><name><surname>Moody</surname><given-names>SA</given-names></name></person-group><article-title>foxD5a, a Xenopus winged helix gene, maintains an immature neural ectoderm via transcriptional repression that is dependent on the C-terminal domain.</article-title><source>Dev Biol</source><year>2001</year><volume>232</volume><fpage>439</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">11401404</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>J</given-names></name><name><surname>Costa</surname><given-names>R</given-names></name><name><surname>Klug</surname><given-names>M</given-names></name><name><surname>Field</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Largaespada</surname><given-names>DA</given-names></name><name><surname>Fletcher</surname><given-names>CF</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Klemsz</surname><given-names>M</given-names></name><name><surname>Hromas</surname><given-names>R</given-names></name></person-group><article-title>Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells.</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>23126</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">8798505</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beysen</surname><given-names>D</given-names></name><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>Messiaen</surname><given-names>L</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>De Baere</surname><given-names>E</given-names></name></person-group><article-title>The human FOXL2 mutation database.</article-title><source>Hum Mutat</source><year>2004</year><volume>24</volume><fpage>189</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15300845</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Or</surname><given-names>SF</given-names></name><name><surname>Tong</surname><given-names>MF</given-names></name><name><surname>Lo</surname><given-names>FM</given-names></name><name><surname>Lam</surname><given-names>TS</given-names></name></person-group><article-title>Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title><source>Chin Med J (Engl)</source><year>2006</year><volume>119</volume><fpage>49</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">16454982</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><article-title>Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title><source>Mutagenesis</source><year>2006</year><volume>21</volume><fpage>35</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16394030</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Shu</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Xing</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>A novel insertion mutation in the FOXL2 gene is detected in a big Chinese family with blepharophimosis-ptosis-epicanthus inversus.</article-title><source>Mutat Res</source><year>2004</year><volume>554</volume><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15450400</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DW</given-names></name></person-group><article-title>Recognizable patterns of human malformation: genetic, embryologic, and clinical aspects.</article-title><source>Major Probl Clin Pediatr</source><year>1970</year><volume>7</volume><fpage>1</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">5538320</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RJ</given-names></name><name><surname>Holcomb</surname><given-names>JD</given-names></name><name><surname>Daiger</surname><given-names>SP</given-names></name><name><surname>Caskey</surname><given-names>CT</given-names></name><name><surname>Pelias</surname><given-names>MZ</given-names></name><name><surname>Alford</surname><given-names>BR</given-names></name><name><surname>Fontenot</surname><given-names>DD</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name></person-group><article-title>Exclusion of Usher syndrome gene from much of chromosome 4.</article-title><source>Cytogenet Cell Genet</source><year>1989</year><volume>50</volume><fpage>102</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2776474</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Minoda</surname><given-names>K</given-names></name></person-group><article-title>Detection of congenital color vision defects using heteroduplex-SSCP analysis.</article-title><source>Jpn J Ophthalmol</source><year>1996</year><volume>40</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">8739504</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Small</surname><given-names>KW</given-names></name><name><surname>Stalvey</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>L</given-names></name><name><surname>Mullen</surname><given-names>L</given-names></name><name><surname>Dickel</surname><given-names>C</given-names></name><name><surname>Beadles</surname><given-names>K</given-names></name><name><surname>Reimer</surname><given-names>R</given-names></name><name><surname>Lessner</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Blepharophimosis syndrome is linked to chromosome 3q.</article-title><source>Hum Mol Genet</source><year>1995</year><volume>4</volume><fpage>443</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7795600</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cocquet</surname><given-names>J</given-names></name><name><surname>De Baere</surname><given-names>E</given-names></name><name><surname>Gareil</surname><given-names>M</given-names></name><name><surname>Pannetier</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Fellous</surname><given-names>M</given-names></name><name><surname>Veitia</surname><given-names>RA</given-names></name></person-group><article-title>Structure, evolution and expression of the FOXL2 transcription unit.</article-title><source>Cytogenet Genome Res</source><year>2003</year><volume>101</volume><fpage>206</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">14684984</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dollfus</surname><given-names>H</given-names></name><name><surname>Stoetzel</surname><given-names>C</given-names></name><name><surname>Riehm</surname><given-names>S</given-names></name><name><surname>Lahlou Boukoffa</surname><given-names>W</given-names></name><name><surname>Bediard Boulaneb</surname><given-names>F</given-names></name><name><surname>Quillet</surname><given-names>R</given-names></name><name><surname>Abu-Eid</surname><given-names>M</given-names></name><name><surname>Speeg-Schatz</surname><given-names>C</given-names></name><name><surname>Francfort</surname><given-names>JJ</given-names></name><name><surname>Flament</surname><given-names>J</given-names></name><name><surname>Veillon</surname><given-names>F</given-names></name><name><surname>Perrin-Schmitt</surname><given-names>F</given-names></name></person-group><article-title>Sporadic and familial blepharophimosis -ptosis-epicanthus inversus syndrome: FOXL2 mutation screen and MRI study of the superior levator eyelid muscle.</article-title><source>Clin Genet</source><year>2003</year><volume>63</volume><fpage>117</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12630957</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Udar</surname><given-names>N</given-names></name><name><surname>Yellore</surname><given-names>V</given-names></name><name><surname>Chalukya</surname><given-names>M</given-names></name><name><surname>Yelchits</surname><given-names>S</given-names></name><name><surname>Silva-Garcia</surname><given-names>R</given-names></name><name><surname>Small</surname><given-names>K</given-names></name></person-group><article-title>BPES Consortium. Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients.</article-title><source>Hum Mutat</source><year>2003</year><volume>22</volume><fpage>222</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12938087</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Baere</surname><given-names>E</given-names></name><name><surname>Beysen</surname><given-names>D</given-names></name><name><surname>Oley</surname><given-names>C</given-names></name><name><surname>Lorenz</surname><given-names>B</given-names></name><name><surname>Cocquet</surname><given-names>J</given-names></name><name><surname>De Sutter</surname><given-names>P</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Dixon</surname><given-names>M</given-names></name><name><surname>Fellous</surname><given-names>M</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name><name><surname>Garza</surname><given-names>A</given-names></name><name><surname>Jonsrud</surname><given-names>C</given-names></name><name><surname>Koivisto</surname><given-names>PA</given-names></name><name><surname>Krause</surname><given-names>A</given-names></name><name><surname>Leroy</surname><given-names>BP</given-names></name><name><surname>Meire</surname><given-names>F</given-names></name><name><surname>Plomp</surname><given-names>A</given-names></name><name><surname>Van Maldergem</surname><given-names>L</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Veitia</surname><given-names>R</given-names></name><name><surname>Messiaen</surname><given-names>L</given-names></name></person-group><article-title>FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.</article-title><source>Am J Hum Genet</source><year>2003</year><volume>72</volume><fpage>478</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">12529855</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Babu</surname><given-names>M</given-names></name><name><surname>Raghunath</surname><given-names>A</given-names></name><name><surname>Venkatesh</surname><given-names>CP</given-names></name></person-group><article-title>Genetic analysis of a five generation Indian family with BPES: a novel missense mutation (p.Y215C).</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>445</fpage><lpage>9</lpage><ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v10/a56/">http://www.molvis.org/molvis/v10/a56/</ext-link><pub-id pub-id-type="pmid">15257268</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caburet</surname><given-names>S</given-names></name><name><surname>Demarez</surname><given-names>A</given-names></name><name><surname>Moumne</surname><given-names>L</given-names></name><name><surname>Fellous</surname><given-names>M</given-names></name><name><surname>De Baere</surname><given-names>E</given-names></name><name><surname>Veitia</surname><given-names>RA</given-names></name></person-group><article-title>A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation.</article-title><source>J Med Genet</source><year>2004</year><volume>41</volume><fpage>932</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15591279</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moumne</surname><given-names>L</given-names></name><name><surname>Fellous</surname><given-names>M</given-names></name><name><surname>Veitia</surname><given-names>RA</given-names></name></person-group><article-title>Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation.</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3557</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16219626</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Chand</surname><given-names>AL</given-names></name><name><surname>Winship</surname><given-names>IM</given-names></name><name><surname>Gersak</surname><given-names>K</given-names></name><name><surname>Aittomaki</surname><given-names>K</given-names></name><name><surname>Shelling</surname><given-names>AN</given-names></name></person-group><article-title>Identification of novel mutations in FOXL2 associated with premature ovarian failure.</article-title><source>Mol Hum Reprod</source><year>2002</year><volume>8</volume><fpage>729</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12149404</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fokstuen</surname><given-names>S</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Blouin</surname><given-names>JL</given-names></name></person-group><article-title>FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients.</article-title><source>Am J Med Genet A</source><year>2003</year><volume>117</volume><fpage>143</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12567411</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosaki</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>T</given-names></name><name><surname>Kosaki</surname><given-names>R</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Matsuo</surname><given-names>N</given-names></name></person-group><article-title>A novel mutation in the FOXL2 gene in a patient with blepharophimosis syndrome: differential role of the polyalanine tract in the development of the ovary and the eyelid.</article-title><source>Ophthalmic Genet</source><year>2002</year><volume>23</volume><fpage>43</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11910558</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>R</given-names></name><name><surname>Murday</surname><given-names>VA</given-names></name><name><surname>Patton</surname><given-names>MA</given-names></name><name><surname>Jeffery</surname><given-names>S</given-names></name></person-group><article-title>Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2.</article-title><source>Genet Test</source><year>2001</year><volume>5</volume><fpage>335</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11960581</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramirez-Castro</surname><given-names>JL</given-names></name><name><surname>Pineda-Trujillo</surname><given-names>N</given-names></name><name><surname>Valencia</surname><given-names>AV</given-names></name><name><surname>Muneton</surname><given-names>CM</given-names></name><name><surname>Botero</surname><given-names>O</given-names></name><name><surname>Trujillo</surname><given-names>O</given-names></name><name><surname>Vasquez</surname><given-names>G</given-names></name><name><surname>Mora</surname><given-names>BE</given-names></name><name><surname>Durango</surname><given-names>N</given-names></name><name><surname>Bedoya</surname><given-names>G</given-names></name><name><surname>Ruiz-Linares</surname><given-names>A</given-names></name></person-group><article-title>Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families.</article-title><source>Am J Med Genet</source><year>2002</year><volume>113</volume><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12400065</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Watkins</surname><given-names>WJ</given-names></name><name><surname>Sloan</surname><given-names>BH</given-names></name><name><surname>Shelling</surname><given-names>AN</given-names></name></person-group><article-title>Blepharophimosis and bilateral Duane syndrome associated with a FOXL2 mutation.</article-title><source>Clin Genet</source><year>2005</year><volume>68</volume><fpage>520</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16283882</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>SC</given-names></name><name><surname>Jang</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Jung</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>JR</given-names></name></person-group><article-title>Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title><source>Clin Genet</source><year>2003</year><volume>64</volume><fpage>485</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">14986827</pub-id></citation></ref></ref-list></back></article> 